News for Johnson & Johnson - Google Finance

Johnson & Johnson Is Reinventing The Party Drug Ketamine To Treat Depression

Thu, 23 May 2013 17:34:01 GMT

Johnson & Johnson Is Reinventing The Party Drug Ketamine To Treat Depression
Forbes - 8 hours ago

Johnson & Johnson Is Reinventing The Party Drug Ketamine To Treat Depression. comments, called-out. Comment Now. Follow Comments Following Comments Unfollow Comments.

Johnson & Johnson says it will submit 10 new medicines for approval by 2017

Thu, 23 May 2013 17:37:20 GMT

Johnson & Johnson says it will submit 10 new medicines for approval by 2017
The Star-Ledger - NJ.com - 8 hours ago

Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.

Johnson & Johnson to seek OK for 10 new treatments by 2017 - MarketWatch (blog)
Johnson & Johnson forecasts 10 new drug applications by 2017 - Asbury Park Press

New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?

Thu, 23 May 2013 13:30:41 GMT

New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?
Minyanville.com - 12 hours ago

(The follicularly-challenged central banker must truly be tearing his hair out right about now, for Rogaine maker Johnson & Johnson (JNJ) has just been assigned a “Sell” rating.) Thus in the space of one spacy session, investors learned the age-old ...

Johnson & Johnson Is Going Big With New Meds

Thu, 23 May 2013 17:50:36 GMT

Johnson & Johnson Is Going Big With New Meds
Wall St. Cheat Sheet - 8 hours ago

The world's biggest maker of healthcare products, Johnson & Johnson (NYSE:JNJ) is ready to prove itself again. With its status as fastest growing pharmaceutical business in 2012, it doesn't come as a surprise that the drugmaker has big plans for the ...

Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit ... - Seeking Alpha
Johnson & Johnson Coverage Initiated at Credit Suisse (JNJ) - Mideast Time

Johnson & Johnson Stock Checkup for May

Mon, 20 May 2013 22:34:23 GMT

Johnson & Johnson Stock Checkup for May
Motley Fool - May 20, 2013

We have checkups for our bodies, our teeth, and even our cars. Why not do the same for our stocks? With that in mind, here is an inaugural monthly checkup for Johnson & Johnson (NYSE: JNJ ) stock. Let's look at three key areas to find out J&J's stock ...

Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback

Thu, 23 May 2013 19:49:01 GMT

Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback
Seeking Alpha - 6 hours ago

Shares of Johnson & Johnson (JNJ) have been in a solid uptrend throughout 2013. As shown in the chart below, the stock looks extended now, so investors should wait for a pullback.

JOHNSON & JOHNSON : to Submit 10 New Product Filings by 2017

Thu, 23 May 2013 12:24:22 GMT

JOHNSON & JOHNSON : to Submit 10 New Product Filings by 2017
4-traders (press release) - 14 hours ago

Johnson & Johnson (JNJ) unit Janssen Pharmaceutical Co. said it plans to submit more than 10 new product filings and more than 25 significant brand line extensions by 2017, which would amount to roughly the same number of new product filings it made in ...

Johnson & Johnson, IVCI, AVI-SPL Address Cloud Managed Services for June ...

Thu, 23 May 2013 07:17:21 GMT

Johnson & Johnson, IVCI, AVI-SPL Address Cloud Managed Services for June ...
PR Web (press release) - 19 hours ago

The VCIG-Live topic this month is Cloud Managed Services.The panel will address issues such as scalability, infrastructure costs, BYOD, and cloud services providers.

How Dividends Change the Game for Johnson & Johnson Stock

Mon, 20 May 2013 18:03:21 GMT

How Dividends Change the Game for Johnson & Johnson Stock
Motley Fool - May 20, 2013

Today, we'll dive deeper into health care and consumer products giant Johnson & Johnson (NYSE: JNJ ) . Owning Johnson & Johnson stock as a dividend play makes all kinds of sense, because the company scores better than the Dow Jones Industrial ...

Johnson & Johnson (JNJ): Are Hedge Funds Right About This Stock?

Thu, 23 May 2013 16:41:16 GMT

Johnson & Johnson (JNJ): Are Hedge Funds Right About This Stock?
Insider Monkey (blog) - 9 hours ago

Johnson & Johnson (NYSE:JNJ) has experienced a decrease in enthusiasm from smart money in recent months. If you'd ask most traders, hedge funds are viewed as unimportant, old investment tools of the past.